EXKIVITY

Peak

mobocertinib succinate

Takeda
NDAORALCAPSULEPriority Review
Approved
Sep 2021
Lifecycle
Peak
Competitive Pressure
0/100

Loss of Exclusivity

LOE Date
May 13, 2035
111 months away
Patent Expiry
May 13, 2035
Exclusivity Expiry
Sep 15, 2028

Patent Records (2)

Patent #ExpiryTypeUse Code
10227342
May 13, 2035
SubstanceProduct
U-3220
9796712
May 13, 2035
SubstanceProduct
—
Company
Takeda
Takeda
TOKYO, Japan
1373 open jobs
External Resources
FDA Drugs@FDA
FDA approval history
RxNorm
Drug nomenclature & identifiers